NCT03836170

Brief Summary

Laparoscopic cholecystectomy (LC) is widely used in the gallbladder stone, gallbladder polyp, gallbladder cancer and other diseases. Some of the patients would develop diarrhea after surgery, and studies have reported an increased risk of colorectal cancer after LC. The aim of the present study was to examine the effects of LC on the gut microbiota.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 11, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2019

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

February 11, 2019

Status Verified

February 1, 2019

Enrollment Period

1 year

First QC Date

February 8, 2019

Last Update Submit

February 8, 2019

Conditions

Keywords

laparoscopic cholecystectomygut microbiota

Outcome Measures

Primary Outcomes (1)

  • Change of gut microbiota after laparoscopic cholecystectomy

    Three months and one year after completion of laparoscopic cholecystectomy therapy, gut microbiota was assessed by 16S rDNA high-throughput sequencing.

    Three months and one year after completion of LC

Study Arms (1)

Laparoscopic cholecystectomy

EXPERIMENTAL

A laparoscopic cholecystectomy was performed to remove the gallbladder

Procedure: Laparoscopic cholecystectomy

Interventions

A special catheter was inserted into the peritoneal cavity, and then about 2-5 liters of carbon dioxide was injected. After reaching a certain pressure, four small holes of 0.5-1.5cm were opened in the abdomen to dissect the structure of the triangle of the gallbladder. The gallbladder duct and gallbladder artery were cut off and closed, and then the entire gallbladder was removed.

Laparoscopic cholecystectomy

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gallbladder polyps diameter mm \>10;
  • The history of the symptoms of patients with gallbladder stones, there was no history of acute attack in the past month;
  • Age \<70 years old;
  • No serious systemic diseases such as diabetes, hypertension, heart disease, lung disease and so on/American anesthesia Association (ASA) grade I or II;
  • BMI\<30;
  • Families have better care and observation, and away from the hospital within 1 hours; patients and their families understand the process of ambulatory surgery (24 hours) and the pros and cons.

You may not qualify if:

  • Less than 18 years old;
  • With previous gastric surgery ;
  • Major systemic diseases ;
  • Pregnancy or lactation;
  • The use of antibiotics or yogurt within 2 months before the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

MeSH Terms

Interventions

Cholecystectomy, Laparoscopic

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Officials

  • Hong Lu, M.D.

    Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor of Division of Gastroenterology and Hepatology of Renji Hospital,Professor of Medicine

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 11, 2019

Study Start

May 15, 2018

Primary Completion

May 20, 2019

Study Completion

June 1, 2019

Last Updated

February 11, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations